Global health security has rarely been more important — nor more fragile. Rapid urbanization, demographics changes, climate-related events, displacement, and conflict are straining health systems and increasing the risk of pandemics and other health threats, including antibiotic-resistant infections.

Combating these threats on multiple fronts depends on the continued strength of the pharmaceutical sector and the scientific advances it delivers in medical countermeasures. However, realizing this potential requires sustained support for innovation, stronger health systems, and enabling policy and financing frameworks.

The pharmaceutical industry remains committed to partnering with governments, research institutions, international organizations, civil society, and industry stakeholders to strengthen preparedness and build a safer, more resilient world for all.